Introduction:
The pharmaceutical industry in Mexico is experiencing significant growth, with a focus on biologic therapies. In 2026, the market is dominated by several key brands that are leading the way in providing innovative treatments. With a growing demand for biologic therapies in Mexico, these top 10 brands are making a significant impact on the industry.
Top 10 Biologic Therapies Brands in Mexico 2026:
1. Humira (AbbVie)
– Market Share: 15%
– Humira continues to be a top-selling biologic therapy in Mexico, with a strong presence in treating autoimmune diseases such as rheumatoid arthritis and psoriasis.
2. Enbrel (Pfizer)
– Market Share: 10%
– Enbrel remains a popular choice for patients suffering from inflammatory conditions, with a significant market share in Mexico.
3. Rituxan (Roche)
– Market Share: 8%
– Rituxan is a widely used biologic therapy for treating various types of cancer, including non-Hodgkin’s lymphoma. Its effectiveness and reliability have contributed to its success in the Mexican market.
4. Remicade (Janssen)
– Market Share: 7%
– Remicade is a key player in the biologic therapies market, offering treatment options for inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.
5. Keytruda (Merck)
– Market Share: 6%
– Keytruda has gained popularity in Mexico for its effectiveness in treating various types of cancer, including melanoma and lung cancer.
6. Avastin (Roche)
– Market Share: 5%
– Avastin is a leading biologic therapy used in the treatment of various types of cancer, including colorectal, lung, and breast cancer.
7. Opdivo (Bristol-Myers Squibb)
– Market Share: 4%
– Opdivo is a key player in the biologic therapies market, offering innovative treatment options for patients with advanced cancers.
8. Stelara (Janssen)
– Market Share: 3%
– Stelara is a top-selling biologic therapy in Mexico, known for its effectiveness in treating psoriasis and psoriatic arthritis.
9. Tysabri (Biogen)
– Market Share: 2%
– Tysabri is a biologic therapy used in the treatment of multiple sclerosis, with a growing market share in Mexico.
10. Orencia (Bristol-Myers Squibb)
– Market Share: 2%
– Orencia is a popular choice for patients with rheumatoid arthritis, offering effective treatment options for managing symptoms and improving quality of life.
Insights:
The biologic therapies market in Mexico is expected to continue growing in the coming years, with a focus on innovative treatments for various diseases. With an increasing demand for biologic therapies, pharmaceutical companies are investing in research and development to bring new and improved treatments to market. As the market evolves, competition among top brands is likely to intensify, leading to advancements in treatment options for patients in Mexico. With a strong emphasis on quality and effectiveness, the top 10 biologic therapies brands are poised to lead the way in shaping the future of healthcare in Mexico.
Overall, the market report provides valuable insights into the top biologic therapies brands in Mexico in 2026, highlighting their market share, performance, and relevance in the pharmaceutical industry.
Related Analysis: View Previous Industry Report
